BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 19, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Cardinal Health will acquire AssuraMed for $2.07 billion

Feb. 15, 2013
By Amanda Pedersen

Asia evolving to become both a major med-tech consumer and player

Feb. 14, 2013
By Holland Johnson
Ask anyone in the med-tech field, or any other manufacturing field for that matter, where  the largest majority of emerging markets for their businesses reside and chances are they will say somewhere in Asia, with China being the first country to likely  cross their lips. With more than 600 billion people and a combined GDP of $2.3 trillion, the ten nations that make up the Association of Southeast Asian Nations (ASEAN) are already experiencing dramatic economic growth. This is especially true of the medical device market, which in 2012 was worth more than $4 billion. Roughly 65% of the $4...
Read More

Deals roundup: Renal Ventures gets majority interest in NJ dialysis clinics

Feb. 14, 2013

Product Briefs

Feb. 14, 2013

People in the News

Feb. 14, 2013

MDD's Ortho Extra

Feb. 14, 2013

The MDD Interview: As season ends, researchers still huddling on concussion studies

Feb. 14, 2013
By Jim Stommen
Stefan Duma, PhD, is professor and head of the Department of Biomedical Engineering in the College of Engineering at Virginia Tech (Blacksburg, Virginia). The founding director of Virginia Tech's Center for Injury Biomechanics, he is internationally recognized for his studies in injury biomechanics and traumatic brain injury and part of the national debate over how to protect young athletes from concussions.
Read More

TASSMA to give small firms one shared voice in sales

Feb. 14, 2013
By Omar Ford

Medtronic launches Advisa, second-gen MRI pacemaker

Feb. 14, 2013
By Amanda Pedersen

Washington roundup: Bacterin hit by FDA warning letters for bone putty, drains

Feb. 14, 2013
By Mark McCarty
Previous 1 2 … 3624 3625 3626 3627 3628 3629 3630 3631 3632 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 18, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Doctor with brain illustration, businessman with dollar sign illustration

    Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

    BioWorld
    Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
  • Illustration of tau accumulating in a neuron cell.

    Biogen AD drug shows tau, cognition benefit, despite trial miss

    BioWorld
    Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing